TY - JOUR AU - Eshhar, Z. AU - Waks, T. AU - Gross, G. AU - Schindler, D. G. PY - 1993 DA - 1993// TI - Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors JO - Proc Natl Acad Sci USA VL - 90 UR - https://doi.org/10.1073/pnas.90.2.720 DO - 10.1073/pnas.90.2.720 ID - Eshhar1993 ER - TY - JOUR AU - Cheadle, E. J. AU - Sheard, V. AU - Hombach, A. A. AU - Chmielewski, M. AU - Riet, T. AU - Berrevoets, C. AU - Schooten, E. AU - Lamers, C. AU - Abken, H. AU - Debets, R. PY - 2012 DA - 2012// TI - Chimeric antigen receptors for T-cell based therapy JO - Methods Mol Biol VL - 907 UR - https://doi.org/10.1007/978-1-61779-974-7_36 DO - 10.1007/978-1-61779-974-7_36 ID - Cheadle2012 ER - TY - JOUR AU - Kochenderfer, J. N. AU - Rosenberg, S. A. PY - 2013 DA - 2013// TI - Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors JO - Nat Rev Clin Oncol VL - 10 UR - https://doi.org/10.1038/nrclinonc.2013.46 DO - 10.1038/nrclinonc.2013.46 ID - Kochenderfer2013 ER - TY - JOUR AU - Porter, D. L. AU - Levine, B. L. AU - Kalos, M. AU - Bagg, A. AU - June, C. H. PY - 2011 DA - 2011// TI - Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1103849 DO - 10.1056/NEJMoa1103849 ID - Porter2011 ER - TY - JOUR AU - Brentjens, R. J. AU - Davila, M. L. AU - Riviere, I. AU - Park, J. AU - Wang, X. AU - Cowell, L. G. AU - Bartido, S. AU - Stefanski, J. AU - Taylor, C. AU - Olszewska, M. PY - 2013 DA - 2013// TI - CD19-Targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3005930 DO - 10.1126/scitranslmed.3005930 ID - Brentjens2013 ER - TY - JOUR AU - Grupp, S. A. AU - Kalos, M. AU - Barrett, D. AU - Aplenc, R. AU - Porter, D. L. AU - Rheingold, S. R. AU - Teachey, D. T. AU - Chew, A. AU - Hauck, B. AU - Wright, J. F. PY - 2013 DA - 2013// TI - Chimeric antigen receptor-modified T cells for acute lymphoid leukemia JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1215134 DO - 10.1056/NEJMoa1215134 ID - Grupp2013 ER - TY - JOUR AU - Xu, X. J. AU - Zhao, H. Z. AU - Tang, Y. M. PY - 2013 DA - 2013// TI - Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials JO - Leuk Lymphoma VL - 54 UR - https://doi.org/10.3109/10428194.2012.715350 DO - 10.3109/10428194.2012.715350 ID - Xu2013 ER - TY - JOUR AU - Haso, W. AU - Lee, D. W. AU - Shah, N. N. AU - Stetler-Stevenson, M. AU - Yuan, C. M. AU - Pastan, I. H. AU - Dimitrov, D. S. AU - Morgan, R. A. AU - FitzGerald, D. J. AU - Barrett, D. M. PY - 2013 DA - 2013// TI - Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-06-438002 DO - 10.1182/blood-2012-06-438002 ID - Haso2013 ER - TY - JOUR AU - Park, J. R. AU - Digiusto, D. L. AU - Slovak, M. AU - Wright, C. AU - Naranjo, A. AU - Wagner, J. AU - Meechoovet, H. B. AU - Bautista, C. AU - Chang, W. C. AU - Ostberg, J. R. PY - 2007 DA - 2007// TI - Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma JO - Mol Ther VL - 15 ID - Park2007 ER - TY - JOUR AU - Louis, C. U. AU - Savoldo, B. AU - Dotti, G. AU - Pule, M. AU - Yvon, E. AU - Myers, G. D. AU - Rossig, C. AU - Russell, H. V. AU - Diouf, O. AU - Liu, E. PY - 2011 DA - 2011// TI - Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-05-354449 DO - 10.1182/blood-2011-05-354449 ID - Louis2011 ER - TY - JOUR AU - Lamers, C. H. AU - Sleijfer, S. AU - van Steenbergen, S. AU - van Elzakker, P. AU - van Krimpen, B. AU - Groot, C. AU - Vulto, A. AU - den Bakker, M. AU - Oosterwijk, E. AU - Debets, R. PY - 2013 DA - 2013// TI - Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity JO - Mol Ther VL - 21 UR - https://doi.org/10.1038/mt.2013.17 DO - 10.1038/mt.2013.17 ID - Lamers2013 ER - TY - JOUR AU - Morgan, R. A. AU - Yang, J. C. AU - Kitano, M. AU - Dudley, M. E. AU - Laurencot, C. M. AU - Rosenberg, S. A. PY - 2010 DA - 2010// TI - Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2010.24 DO - 10.1038/mt.2010.24 ID - Morgan2010 ER - TY - JOUR AU - Kandalaft, L. E. AU - Powell, D. J. AU - Coukos, G. PY - 2012 DA - 2012// TI - A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-157 DO - 10.1186/1479-5876-10-157 ID - Kandalaft2012 ER - TY - JOUR AU - Schlimper, C. AU - Hombach, A. A. AU - Abken, H. AU - Schmidt-Wolf, I. G. PY - 2012 DA - 2012// TI - Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells JO - Clin Dev Immunol VL - 201 ID - Schlimper2012 ER - TY - JOUR AU - Morgan, R. A. AU - Johnson, L. A. AU - Davis, J. L. AU - Zheng, Z. AU - Woolard, K. D. AU - Reap, E. A. AU - Feldman, S. A. AU - Chinnasamy, N. AU - Kuan, C. T. AU - Song, H. PY - 2012 DA - 2012// TI - Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma JO - Hum Gene Ther VL - 23 UR - https://doi.org/10.1089/hum.2012.041 DO - 10.1089/hum.2012.041 ID - Morgan2012 ER - TY - JOUR AU - Kloss, C. C. AU - Condomines, M. AU - Cartellieri, M. AU - Bachmann, M. AU - Sadelain, M. PY - 2013 DA - 2013// TI - Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2459 DO - 10.1038/nbt.2459 ID - Kloss2013 ER - TY - JOUR AU - Shirasu, N. AU - Kuroki, M. PY - 2012 DA - 2012// TI - Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes JO - Anticancer Res VL - 32 ID - Shirasu2012 ER - TY - JOUR AU - Hudecek, M. AU - Lupo-Stanghellini, M. T. AU - Kosasih, P. L. AU - Sommermeyer, D. AU - Jensen, M. C. AU - Rader, C. AU - Riddell, S. R. PY - 2013 DA - 2013// TI - Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0330 DO - 10.1158/1078-0432.CCR-13-0330 ID - Hudecek2013 ER - TY - JOUR AU - Chinnasamy, D. AU - Tran, E. AU - Yu, Z. AU - Morgan, R. A. AU - Restifo, N. P. AU - Rosenberg, S. A. PY - 2013 DA - 2013// TI - Simultaneous targeting of tumor antigens and the tumor vasculature using T lymphocyte transfer synergize to induce regression of established tumors in mice JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3913 DO - 10.1158/0008-5472.CAN-12-3913 ID - Chinnasamy2013 ER - TY - JOUR AU - Zhang, T. AU - Barber, A. AU - Sentman, C. L. PY - 2007 DA - 2007// TI - Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2251 DO - 10.1158/0008-5472.CAN-07-2251 ID - Zhang2007 ER - TY - JOUR AU - Hombach, A. AU - Hombach, A. A. AU - Abken, H. PY - 2010 DA - 2010// TI - Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc spacer domain in the extracellular moiety of chimeric antigen receptors avoids off-target activation and unintended initiation of an innate immune response JO - Gene Ther VL - 17 UR - https://doi.org/10.1038/gt.2010.91 DO - 10.1038/gt.2010.91 ID - Hombach2010 ER - TY - JOUR AU - Guest, R. D. AU - Hawkins, R. E. AU - Kirillova, N. AU - Cheadle, E. J. AU - Arnold, J. AU - O’Neill, A. AU - Irlam, J. AU - Chester, K. A. AU - Kemshead, J. T. AU - Shaw, D. M. PY - 2005 DA - 2005// TI - The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens JO - J Immunother VL - 28 UR - https://doi.org/10.1097/01.cji.0000161397.96582.59 DO - 10.1097/01.cji.0000161397.96582.59 ID - Guest2005 ER - TY - JOUR AU - Bridgeman, J. S. AU - Hawkins, R. E. AU - Bagley, S. AU - Blaylock, M. AU - Holland, M. AU - Gilham, D. E. PY - 2010 DA - 2010// TI - The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex JO - J Immunol VL - 184 UR - https://doi.org/10.4049/jimmunol.0901766 DO - 10.4049/jimmunol.0901766 ID - Bridgeman2010 ER - TY - JOUR AU - Savoldo, B. AU - Ramos, C. A. AU - Liu, E. AU - Mims, M. P. AU - Keating, M. J. AU - Carrum, G. AU - Kamble, R. T. AU - Bollard, C. M. AU - Gee, A. P. AU - Mei, Z. PY - 2011 DA - 2011// TI - CD28 Costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI46110 DO - 10.1172/JCI46110 ID - Savoldo2011 ER - TY - JOUR AU - Tammana, S. AU - Huang, X. AU - Wong, M. AU - Milone, M. C. AU - Ma, L. AU - Levine, B. L. AU - June, C. H. AU - Wagner, J. E. AU - Blazar, B. R. AU - Zhou, X. PY - 2010 DA - 2010// TI - 4-1BB And CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies JO - Hum Gene Ther VL - 21 UR - https://doi.org/10.1089/hum.2009.122 DO - 10.1089/hum.2009.122 ID - Tammana2010 ER - TY - JOUR AU - Finney, H. M. AU - Akbar, A. N. AU - Lawson, A. D. PY - 2004 DA - 2004// TI - Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain JO - J Immunol VL - 172 UR - https://doi.org/10.4049/jimmunol.172.1.104 DO - 10.4049/jimmunol.172.1.104 ID - Finney2004 ER - TY - JOUR AU - Milone, M. C. AU - Fish, J. D. AU - Carpenito, C. AU - Carroll, R. G. AU - Binder, G. K. AU - Teachey, D. AU - Samanta, M. AU - Lakhal, M. AU - Gloss, B. AU - Danet-Desnoyers, G. PY - 2009 DA - 2009// TI - Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo JO - Mol Ther VL - 17 UR - https://doi.org/10.1038/mt.2009.83 DO - 10.1038/mt.2009.83 ID - Milone2009 ER - TY - JOUR AU - Shen, C. J. AU - Yang, Y. X. AU - Han, E. Q. AU - Cao, N. AU - Wang, Y. F. AU - Wang, Y. AU - Zhao, Y. Y. AU - Zhao, L. M. AU - Cui, J. AU - Gupta, P. PY - 2013 DA - 2013// TI - Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma JO - J Hematol Oncol VL - 6 UR - https://doi.org/10.1186/1756-8722-6-33 DO - 10.1186/1756-8722-6-33 ID - Shen2013 ER - TY - JOUR AU - Klebanoff, C. A. AU - Gattinoni, L. AU - Restifo, N. P. PY - 2012 DA - 2012// TI - Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e31827806e6 DO - 10.1097/CJI.0b013e31827806e6 ID - Klebanoff2012 ER - TY - JOUR AU - Berger, C. AU - Jensen, M. C. AU - Lansdorp, P. M. AU - Gough, M. AU - Elliott, C. AU - Riddell, S. R. PY - 2008 DA - 2008// TI - Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates JO - J Clin Invest VL - 118 UR - https://doi.org/10.1172/JCI32103 DO - 10.1172/JCI32103 ID - Berger2008 ER - TY - JOUR AU - Gattinoni, L. AU - Lugli, E. AU - Ji, Y. AU - Pos, Z. AU - Paulos, C. M. AU - Quigley, M. F. AU - Almeida, J. R. AU - Gostick, E. AU - Yu, Z. AU - Carpenito, C. PY - 2011 DA - 2011// TI - A human memory T cell subset with stem cell-like properties JO - Nat Med VL - 17 UR - https://doi.org/10.1038/nm.2446 DO - 10.1038/nm.2446 ID - Gattinoni2011 ER - TY - JOUR AU - Wang, X. AU - Naranjo, A. AU - Brown, C. E. AU - Bautista, C. AU - Wong, C. W. AU - Chang, W. C. AU - Aguilar, B. AU - Ostberg, J. R. AU - Riddell, S. R. AU - Forman, S. J. PY - 2012 DA - 2012// TI - Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e318270dec7 DO - 10.1097/CJI.0b013e318270dec7 ID - Wang2012 ER - TY - JOUR AU - Turtle, C. J. AU - Riddell, S. R. PY - 2010 DA - 2010// TI - Artificial antigen-presenting cells for use in adoptive immunotherapy JO - Cancer J VL - 16 UR - https://doi.org/10.1097/PPO.0b013e3181eb33a6 DO - 10.1097/PPO.0b013e3181eb33a6 ID - Turtle2010 ER - TY - JOUR AU - Antony, P. A. AU - Paulos, C. M. AU - Ahmadzadeh, M. AU - Akpinarli, A. AU - Palmer, D. C. AU - Sato, N. AU - Kaiser, A. AU - Hinrichs, C. S. AU - Klebanoff, C. A. AU - Tagaya, Y. PY - 2006 DA - 2006// TI - Interleukin-2-dependent mechanisms of tolerance and immunity in vivo JO - J Immunol VL - 176 UR - https://doi.org/10.4049/jimmunol.176.9.5255 DO - 10.4049/jimmunol.176.9.5255 ID - Antony2006 ER - TY - JOUR AU - Mueller, Y. M. AU - Makar, V. AU - Bojczuk, P. M. AU - Witek, J. AU - Katsikis, P. D. PY - 2003 DA - 2003// TI - IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells JO - Int Immunol VL - 15 UR - https://doi.org/10.1093/intimm/dxg013 DO - 10.1093/intimm/dxg013 ID - Mueller2003 ER - TY - JOUR AU - Rao, R. R. AU - Li, Q. AU - Odunsi, K. AU - Shrikant, P. A. PY - 2010 DA - 2010// TI - The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and eomesodermin JO - Immunity VL - 32 UR - https://doi.org/10.1016/j.immuni.2009.10.010 DO - 10.1016/j.immuni.2009.10.010 ID - Rao2010 ER - TY - JOUR AU - Colovos, C. AU - Villena-Vargas, J. AU - Adusumilli, P. S. PY - 2012 DA - 2012// TI - Safety and stability of retrovirally transduced chimeric antigen receptor T cells JO - Immunotherapy VL - 4 UR - https://doi.org/10.2217/imt.12.91 DO - 10.2217/imt.12.91 ID - Colovos2012 ER - TY - JOUR AU - Scholler, J. AU - Brady, T. L. AU - Binder-Scholl, G. AU - Hwang, W. T. AU - Plesa, G. AU - Hege, K. M. AU - Vogel, A. N. AU - Kalos, M. AU - Riley, J. L. AU - Deeks, S. G. PY - 2012 DA - 2012// TI - Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003761 DO - 10.1126/scitranslmed.3003761 ID - Scholler2012 ER - TY - JOUR AU - McGarrity, G. J. AU - Hoyah, G. AU - Winemiller, A. AU - Andre, K. AU - Stein, D. AU - Blick, G. AU - Greenberg, R. N. AU - Kinder, C. AU - Zolopa, A. AU - Binder-Scholl, G. PY - 2013 DA - 2013// TI - Patient monitoring and follow-up in lentiviral clinical trials JO - J Gene Med VL - 15 UR - https://doi.org/10.1002/jgm.2691 DO - 10.1002/jgm.2691 ID - McGarrity2013 ER - TY - JOUR AU - Schroers, R. AU - Hildebrandt, Y. AU - Hasenkamp, J. AU - Glass, B. AU - Lieber, A. AU - Wulf, G. AU - Piesche, M. PY - 2004 DA - 2004// TI - Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors JO - Exp Hematol VL - 32 UR - https://doi.org/10.1016/j.exphem.2004.03.010 DO - 10.1016/j.exphem.2004.03.010 ID - Schroers2004 ER - TY - JOUR AU - Maiti, S. N. AU - Huls, H. AU - Singh, H. AU - Dawson, M. AU - Figliola, M. AU - Olivares, S. AU - Rao, P. AU - Zhao, Y. J. AU - Multani, A. AU - Yang, G. PY - 2013 DA - 2013// TI - Sleeping beauty system to redirect T-cell specificity for human applications JO - J Immunother VL - 36 UR - https://doi.org/10.1097/CJI.0b013e3182811ce9 DO - 10.1097/CJI.0b013e3182811ce9 ID - Maiti2013 ER - TY - JOUR AU - Nakazawa, Y. AU - Huye, L. E. AU - Salsman, V. S. AU - Leen, A. M. AU - Ahmed, N. AU - Rollins, L. AU - Dotti, G. AU - Gottschalk, S. M. AU - Wilson, M. H. AU - Rooney, C. M. PY - 2011 DA - 2011// TI - PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2011.131 DO - 10.1038/mt.2011.131 ID - Nakazawa2011 ER - TY - JOUR AU - Barrett, D. M. AU - Zhao, Y. AU - Liu, X. AU - Jiang, S. AU - Carpenito, C. AU - Kalos, M. AU - Carroll, R. G. AU - June, C. H. AU - Grupp, S. A. PY - 2011 DA - 2011// TI - Treatment of advanced leukemia in mice with mRNA engineered T cells JO - Hum Gene Ther VL - 22 UR - https://doi.org/10.1089/hum.2011.070 DO - 10.1089/hum.2011.070 ID - Barrett2011 ER - TY - JOUR AU - Dudley, M. E. AU - Yang, J. C. AU - Sherry, R. AU - Hughes, M. S. AU - Royal, R. AU - Kammula, U. AU - Robbins, P. F. AU - Huang, J. AU - Citrin, D. E. AU - Leitman, S. F. PY - 2008 DA - 2008// TI - Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.5449 DO - 10.1200/JCO.2008.16.5449 ID - Dudley2008 ER - TY - JOUR AU - Rosenberg, S. A. AU - Yang, J. C. AU - Sherry, R. M. AU - Kammula, U. S. AU - Hughes, M. S. AU - Phan, G. Q. AU - Citrin, D. E. AU - Restifo, N. P. AU - Robbins, P. F. AU - Wunderlich, J. R. PY - 2011 DA - 2011// TI - Durable complete responses in heavily pretreted patients with metastatic melanoma using T cell transfer immunotherapy JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0116 DO - 10.1158/1078-0432.CCR-11-0116 ID - Rosenberg2011 ER - TY - JOUR AU - Kalos, M. AU - Levine, B. L. AU - Porter, D. L. AU - Katz, S. AU - Grupp, S. A. AU - Bagg, A. AU - June, C. H. PY - 2011 DA - 2011// TI - T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002842 DO - 10.1126/scitranslmed.3002842 ID - Kalos2011 ER - TY - JOUR AU - Curiel, T. J. AU - Coukos, G. AU - Zou, L. AU - Alvarez, X. AU - Cheng, P. AU - Mottram, P. AU - Evdemon-Hogan, M. AU - Conejo-Garcia, J. R. AU - Zhang, L. AU - Burow, M. PY - 2004 DA - 2004// TI - Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival JO - Nature Med VL - 10 UR - https://doi.org/10.1038/nm1093 DO - 10.1038/nm1093 ID - Curiel2004 ER - TY - JOUR AU - Gattinoni, L. AU - Finkelstein, S. E. AU - Klebanoff, C. A. AU - Antony, P. A. AU - Palmer, D. C. AU - Spiess, P. J. AU - Hwang, L. N. AU - Yu, Z. AU - Wrzesinski, C. AU - Heimann, D. M. PY - 2005 DA - 2005// TI - Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumour-specific CD8+ T cells JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20050732 DO - 10.1084/jem.20050732 ID - Gattinoni2005 ER - TY - JOUR AU - Russo, V. AU - Tanzarella, S. AU - Dalerba, P. AU - Rigatti, D. AU - Rovere, P. AU - Villa, A. AU - Bordignon, C. AU - Traversari, C. PY - 2000 DA - 2000// TI - Dendritic cells acquire the MAGE-3 human tumour antigen from apoptotic cells and induce a class I-restricted T cell response JO - Proc Natl Acad Sci USA VL - 97 UR - https://doi.org/10.1073/pnas.040540197 DO - 10.1073/pnas.040540197 ID - Russo2000 ER - TY - JOUR AU - Brentjens, R. AU - Yeh, R. AU - Bernal, Y. AU - Riviere, I. AU - Sadelain, M. PY - 2010 DA - 2010// TI - Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial JO - Mol Ther VL - 18 UR - https://doi.org/10.1038/mt.2010.31 DO - 10.1038/mt.2010.31 ID - Brentjens2010 ER - TY - JOUR AU - Kochenderfer, J. N. AU - Dudley, M. E. AU - Feldman, S. A. AU - Wilson, W. H. AU - Spaner, D. E. AU - Maric, I. AU - Stetler-Stevenson, M. AU - Phan, G. Q. AU - Hughes, M. S. AU - Sherry, R. M. PY - 2012 DA - 2012// TI - B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric- antigen -receptor-transduced T cells JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-10-384388 DO - 10.1182/blood-2011-10-384388 ID - Kochenderfer2012 ER - TY - JOUR AU - Di Stasi, A. AU - Tey, S. K. AU - Dotti, G. AU - Fujita, Y. AU - Kennedy-Nasser, A. AU - Martinez, C. AU - Straathof, K. AU - Liu, E. AU - Durett, A. G. AU - Grilley, B. PY - 2011 DA - 2011// TI - Inducible apoptosis as a safety switch for adoptive cell therapy JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1106152 DO - 10.1056/NEJMoa1106152 ID - Di Stasi2011 ER -